Clinical Cell Culture Signs Supply Agreement with CSL Ltd For Key Component of Tissue HarvestingThursday September 28 8:37 PMReCell (R) is a unique medical device that assists plastic, cosmetic, dermatology and burn surgeons in repairing a wide range of skin defects. ReCell (R) is intended for use in patients with injuries of up to 2% of the body surface or 320cmSq. Under the terms of the agreement, C3 has committed to a minimum quantity of Trypsin from CSL over a 2 year period, resulting in a financial commitment of $1 million. CEO Bob Atwill said he was delighted that the supply of Trypsin had been secured with CSL, Australia's leading biopharmaceutical company. "This agreement locks in the supply of enhanced formulations of Trypsin and the minimum purchase quantity reflects the anticipated increase in ReCell(R) sales in the next 2 years." "We have worked with CSL for a number of years and we look forward to developing our relationship in the supply of this key component," said Mr Atwill. President Asia Pacific CSL Bioplasma Tom Giarla said this agreement will continue our close working partnership and enable us to jointly develop the Trypsin product and technology platform. About CLINICAL CELL CULTURE LIMITED: Clinical Cell Culture (C3) is a publicly listed biomedical company that develops and distributes a number of tissue-engineered products for the treatment of wounds and other skin defects. Using proprietary tissue-culture/ collection technology, C3 is able to provide innovative treatment solutions derived from the patients own skin, to enhance healing rates, reduce scar formation and reintroduce pigmentation into the skin. About CSL LIMITED: Development, manufacturing and marketing of pharmaceutical and diagnostic products, cell culture media and human plasma fractions. Contact: John McGlue Porter Novelli Tel: +61 (0) 8 9386 1233 Mob: +61 (0) 417 926 915 Source: CLINICAL CELL CULTURE LIMITED Copyright (C) 2006 ACN Newswire. All rights reserved. |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright ©
2009
Yahoo!7 Pty Limited. All rights reserved.
Advertise with Us -
Privacy Policy - Terms of Service.